WAVE Life Sciences Ltd
NASDAQ:WVE
WAVE Life Sciences Ltd
NASDAQ:WVE
Price:
6.14 USD
4.42%
Market Closed
Updated:
May 5, 2024
WAVE Life Sciences Ltd
Cash from Investing Activities
|
WAVE Life Sciences Ltd
Cash from Investing Activities Peer Comparison
Comparables:
H02
H
1J5
I
42C
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Cash from Investing Activities
-$1.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Cash from Investing Activities
S$258m
|
CAGR 3-Years
23%
|
CAGR 5-Years
16%
|
CAGR 10-Years
61%
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Cash from Investing Activities
-S$1.5m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Cash from Investing Activities
S$704k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is WAVE Life Sciences Ltd's Cash from Investing Activities?
Cash from Investing Activities
-1.1m
USD
-1.1m
USD
Based on the financial report for Dec 31, 2023, WAVE Life Sciences Ltd's Cash from Investing Activities amounts to -1.1m USD.
What is WAVE Life Sciences Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
35%
35%
Over the last year, the Cash from Investing Activities growth was 12%. The average annual Cash from Investing Activities growth rates for WAVE Life Sciences Ltd have been 6% over the past three years , 35% over the past five years .
You don't have any saved screeners yet
